ConsiGma™ Continuous Tableting Line – GEA Pharma Systems
Posted on February 27, 2013
From powder to tablet in 20 minutes: improved process control, higher tablet quality with higher process yield.
Since its launch five years ago, ConsiGma™ from GEA Pharma Systems, has created a permanent change in pharmaceutical solid dose manufacturing. Continuous processing has opened up a wealth of opportunities to improve quality, flexibility and consistency while allowing manufacturers to move seamlessly from R&D operations to full production on the same equipment. The company now has many reference sites worldwide and its global competence centre in Antwerp has conducted tests on over 100 formulations for 50+ customers.
Continuous manufacturing makes batch sizes simply a factor of running time. The same ConsiGma™ machine can run 500g of product in R&D, but also clinical trial, launch size, and any production batches. This allows manufacturers to reduce costs and development time and bring products to market faster.
ConsiGma™ can do particle design and mimic any traditional batch granulation process with better, more consistent quality. The granules have generally a better intra-granular porosity with better compressibility characteristics so tablet presses run more efficiently at maximum speed with hardly any weight adjustments.
ConsiGma has a modular design that can incorporate different granulation techniques, the measurement of critical quality attributes, compression and even coating. Other benefits include: fast installation; fast return on investment; and low energy consumption - all contributing to to lowest possible total cost of ownership.
For further editorial information contact:
Steve Jordan
The Words Workshop Ltd.
26 Swanwick Lane, Milton Keynes, MK10 9LD
Tel: (44) (0) 1908 695500 Fax: (44) (0) 1908 690099
E-mail: steve@thewordsworkshop.co.uk
web:
www.geapharmasystems.com
For further business information contact:
Kris Schoeters
GEA Pharma Systems nv – Collette™
Keerbaan 70, B-2160 Wommelgem, Belgium
Tel +32 3 350 12 88. Fax +32 3 353 20 55
E-mail: kris.schoeters@geagroup.com
web:
www.geapharmasystems.com
